Skip to main content

Advertisement

Log in

The role of pigment epithelial detachment in AMD with submacular hemorrhage treated with vitrectomy and subretinal co-application of rtPA and anti-VEGF

  • Retinal Disorders
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To assess the incidence of pigment epithelial detachment (PED) in age-related macular degeneration (AMD) with submacular hemorrhage (SMH) and its response to treatment with pars plana vitrectomy (ppV), subretinal co-application of recombinant tissue plasminogen activator (rtPA) and anti-VEGF, and an intravitreal gas tamponade.

Methods

Consecutive interventional case series of 132 eyes of 129 patients with neovascular AMD with SMH. All eyes underwent ppV with subretinal co-application of rtPA and bevacizumab followed by a gas tamponade. Postoperatively, two additional intravitreal anti-VEGF injections were applied monthly, followed by intravitreal anti-VEGF injections applied PRN thereafter. PEDs and SMHs were evaluated with SD-OCT pre- and postoperatively.

Results

Preoperatively, 88 of 132 (67%) eyes were examined by OCT, and in 81 of these eyes the RPE could be visualised. A PED was found in 74 (91%) eyes, and no PED was found in five (6%) eyes. Median height of preoperative PED was 503 μm (range 150–1242, n = 65) and reduced to 344 (n = 62) and 306 μm (n = 27) after 3 and 12 months respectively. Two eyes showed a pre-existing rip of the RPE. Postoperatively, a rip was documented in 12 of 128 (9%) eyes. Median height of SMH was 762 μm (range 217–1840), median diameter was 4.3 (1.5-15) disc diameter. A complete displacement of the SMH from the fovea was achieved in 112 of 129 (87%) eyes. Overall, median best-corrected logMAR visual acuity (BCVA) improved significantly from preoperative 1.6 (0.5–2.0, n = 132) to 1.0 (0.2–2.0) 3 (n = 132) and 12 months (n = 74) postoperatively. Excluding eyes with pre-existing macular scars (n = 22), BCVA 3 months postoperatively was 0.8. Height of PED or SMH did not correlate with postoperatively BCVA, while size of SMH showed a mild correlation (rho = 0.25, p = 0.005).

Conclusion

PpV with subretinal co-application of rtPA and bevacizumab and an intravitreal gas tamponade effectively displaces SMH and improves BCVA. Preoperatively, PED is found in the majority of eyes. Height of PED or SMH did not correlate with postoperatively BCVA. Tears of the RPE occur as frequently as in exudative AMD without SMH.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Pauleikhoff D, Löffert D, Spital G et al (2002) Pigment epithelial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implications. Graefes Arch Clin Exp Ophthalmol 240:533–538

    Article  CAS  PubMed  Google Scholar 

  2. Baba T, Kitahashi M, Kubota-Taniai M et al (2012) Two-year course of subfoveal pigment epithelial detachment in eyes with age-related macular degeneration and visual acuity better than 20/40. Ophthalmologica 228:102–109

    Article  PubMed  Google Scholar 

  3. Dirani A, Ambresin A, Marchionno L et al (2015) Factors influencing the treatment response of pigment epithelium detachment in age-related macular degeneration. Am J Ophthalmol 160:732–738

    Article  PubMed  Google Scholar 

  4. Clemens CR, Eter N (2016) Retinal pigment epithelium tears: risk factors, mechanism and therapeutic monitoring. Ophthalmologica 235:1–9

    Article  CAS  PubMed  Google Scholar 

  5. Treumer F, Klatt C, Roider J, Hillenkamp J (2010) Subretinal coapplication of recombinant tissue plasminogen activator and bevacizumab for neovascular age-related macular degeneration with submacular haemorrhage. Br J Ophthalmol 94:48–53

    Article  CAS  PubMed  Google Scholar 

  6. Treumer F, Roider J, Hillenkamp J (2012) Long-term outcome of subretinal coapplication of rtPA and bevacizumab followed by repeated intravitreal anti-VEGF injections for neovascular AMD with submacular haemorrhage. Br J Ophthalmol 96:708–713

    Article  PubMed  Google Scholar 

  7. González-López JJ, McGowan G, Chapman E, Yorston D (2016) Vitrectomy with subretinal tissue plasminogen activator and ranibizumab for submacular haemorrhages secondary to age-related macular degeneration: retrospective case series of 45 consecutive cases. Eye (Lond Engl). doi:10.1038/eye.2016.65

    Google Scholar 

  8. Bach M, Kommerell G (1998) Determining visual acuity using European normal values: scientific principles and possibilities for automatic measurement. Klin Monatsbl Augenheilkd 212:190–195

    Article  CAS  PubMed  Google Scholar 

  9. Joussen AM, Heussen FMA, Joeres S et al (2006) Autologous translocation of the choroid and retinal pigment epithelium in age-related macular degeneration. Am J Ophthalmol 142:17–30

    Article  PubMed  Google Scholar 

  10. Heimes B, Lommatzsch A, Zeimer M et al (2011) Long-term visual course after anti-VEGF therapy for exudative AMD in clinical practice evaluation of the German reinjection scheme. Graefes Arch Clin Exp Ophthalmol 249:639–644

    Article  CAS  PubMed  Google Scholar 

  11. Stanescu-Segall D, Balta F, Jackson TL (2016) Submacular hemorrhage in neovascular age-related macular degeneration: a synthesis of the literature. Surv Ophthalmol 61:18–32

    Article  PubMed  Google Scholar 

  12. Sandhu SS, Manvikar S, Steel DHW (2010) Displacement of submacular hemorrhage associated with age-related macular degeneration using vitrectomy and submacular tPA injection followed by intravitreal ranibizumab. Clin Ophthalmol 4:637–642

    PubMed  PubMed Central  Google Scholar 

  13. Hillenkamp J, Surguch V, Framme C et al (2010) Management of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activator. Graefes Arch Clin Exp Ophthalmol 248:5–11

    Article  CAS  PubMed  Google Scholar 

  14. Casswell AG, Kohen D, Bird AC (1985) Retinal pigment epithelial detachments in the elderly: classification and outcome. Br J Ophthalmol 69:397–403

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Shah CP, Hsu J, Garg SJ et al (2006) Retinal pigment epithelial tear after intravitreal bevacizumab injection. Am J Ophthalmol 142:1070–1072

    Article  CAS  PubMed  Google Scholar 

  16. Singh RP, Sears JE (2006) Retinal pigment epithelial tears after pegaptanib injection for exudative age-related macular degeneration. Am J Ophthalmol 142:160–162

    Article  CAS  PubMed  Google Scholar 

  17. Saito M, Kano M, Itagaki K et al (2013) Retinal pigment epithelium tear after intravitreal aflibercept injection. Clin Ophthalmol Auckl NZ 7:1287–1289

    Article  Google Scholar 

  18. Carvounis PE, Kopel AC, Benz MS (2007) Retinal pigment epithelium tears following ranibizumab for exudative age-related macular degeneration. Am J Ophthalmol 143:504–505

    Article  CAS  PubMed  Google Scholar 

  19. Chang LK, Flaxel CJ, Lauer AK, Sarraf D (2007) RPE tears after pegaptanib treatment in age-related macular degeneration. Retina Phila Pa 27:857–863

    Article  Google Scholar 

  20. Sarraf D, Chan C, Rahimy E, Abraham P (2013) Prospective evaluation of the incidence and risk factors for the development of RPE tears after high- and low-dose ranibizumab therapy. Retina Phila Pa 33:1551–1557

    Article  CAS  Google Scholar 

  21. Chan CK, Abraham P, Meyer CH et al (2010) Optical coherence tomography-measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections. Retina Phila Pa 30:203–211

    Article  Google Scholar 

  22. Doguizi S, Ozdek S (2014) Pigment epithelial tears associated with anti-VEGF therapy: incidence, long-term visual outcome, and relationship with pigment epithelial detachment in age-related macular degeneration. Retina Phila Pa 34:1156–1162

    Article  CAS  Google Scholar 

  23. Clemens CR, Bastian N, Alten F et al (2014) Prediction of retinal pigment epithelial tear in serous vascularized pigment epithelium detachment. Acta Ophthalmol (Copenh) 92:e50–56

    Article  CAS  Google Scholar 

  24. Clemens CR, Alten F, Eter N (2015) Reading the signs: Microrips as a prognostic sign for impending RPE tear development. Acta Ophthalmol (Copenh) 93:e600–602

    Article  Google Scholar 

  25. Mukai R, Sato T, Kishi S (2014) Precursor stage of retinal pigment epithelial tear in age-related macular degeneration. Acta Ophthalmol (Copenh) 92:e407–408

    Article  CAS  Google Scholar 

  26. Lehmann B, Heimes B, Gutfleisch M et al (2015) Serous vascularized pigment epithelial detachment in exudative AMD. Morphological typing and risk of tears in the RPE. Ophthalmologe 112:49–56

    Article  CAS  PubMed  Google Scholar 

  27. Kim JH, Chang YS, Kim JW et al (2014) Intravitreal anti-vascular endothelial growth factor for submacular hemorrhage from choroidal neovascularization. Ophthalmology 121:926–935

    Article  PubMed  Google Scholar 

  28. CATT Research Group, Martin DF, Maguire MG (2011) Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 364:1897–1908

    Article  Google Scholar 

Download references

Acknowledgements

We thank Jürgen Hedderich from the Institute of Medical Informatics and Statistics, University Medical Center Schleswig-Holstein, Kiel, Germany for his help with the statistical calculations.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to F. Treumer.

Ethics declarations

Conflict of Interest

All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.

Funding

No funding was received for this research.

Ethical approval

The analysis have been approved by the institutional research ethics committee. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Treumer, F., Wienand, S., Purtskhvanidze, K. et al. The role of pigment epithelial detachment in AMD with submacular hemorrhage treated with vitrectomy and subretinal co-application of rtPA and anti-VEGF. Graefes Arch Clin Exp Ophthalmol 255, 1115–1123 (2017). https://doi.org/10.1007/s00417-017-3620-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-017-3620-2

Keywords

Navigation